Mead Over

2.6k total citations
67 papers, 1.7k citations indexed

About

Mead Over is a scholar working on Economics and Econometrics, Infectious Diseases and General Health Professions. According to data from OpenAlex, Mead Over has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Economics and Econometrics, 30 papers in Infectious Diseases and 17 papers in General Health Professions. Recurrent topics in Mead Over's work include HIV/AIDS Impact and Responses (35 papers), HIV/AIDS Research and Interventions (29 papers) and Poverty, Education, and Child Welfare (16 papers). Mead Over is often cited by papers focused on HIV/AIDS Impact and Responses (35 papers), HIV/AIDS Research and Interventions (29 papers) and Poverty, Education, and Child Welfare (16 papers). Mead Over collaborates with scholars based in United States, United Kingdom and South Africa. Mead Over's co-authors include Peter Piot, Alexander Zipf, Arne Schilling, Tord Kjellström, Shantayanan Devarajan, Gesine Meyer‐Rath, Christopher J L Murray, Richard Feachem, Margaret A. Phillips and Anne A. Scitovsky and has published in prestigious journals such as Science, The Lancet and PLoS ONE.

In The Last Decade

Mead Over

63 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mead Over	639	618	456	322	315	67	1.7k
Sergio Bautista‐Arredondo	339 0.5×	729 1.2×	550 1.2×	120 0.4×	546 1.7×	139	1.8k
Samuel J. Clark	559 0.9×	688 1.1×	1.0k 2.3×	286 0.9×	536 1.7×	101	3.1k
James Newell	477 0.7×	951 1.5×	869 1.9×	91 0.3×	878 2.8×	53	2.4k
Samuel Manda	232 0.4×	474 0.8×	471 1.0×	78 0.2×	411 1.3×	126	2.1k
Abraham J Herbst	196 0.3×	574 0.9×	330 0.7×	92 0.3×	333 1.1×	12	1.3k
Michael Bartoš	206 0.3×	709 1.1×	560 1.2×	79 0.2×	328 1.0×	29	1.6k
Paul Revill	632 1.0×	783 1.3×	505 1.1×	58 0.2×	512 1.6×	85	2.0k
Abdhalah Ziraba	182 0.3×	431 0.7×	665 1.5×	221 0.7×	370 1.2×	52	2.1k
Kenneth Sherr	485 0.8×	759 1.2×	1.2k 2.6×	94 0.3×	479 1.5×	119	2.7k
Debra Jackson	193 0.3×	746 1.2×	1.1k 2.4×	118 0.4×	486 1.5×	111	2.5k

Countries citing papers authored by Mead Over

Since Specialization

Citations

This map shows the geographic impact of Mead Over's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mead Over with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mead Over more than expected).

Fields of papers citing papers by Mead Over

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mead Over. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mead Over. The network helps show where Mead Over may publish in the future.

Co-authorship network of co-authors of Mead Over

This figure shows the co-authorship network connecting the top 25 collaborators of Mead Over. A scholar is included among the top collaborators of Mead Over based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mead Over. Mead Over is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halperin, Daniel T., Norman Hearst, Stephen Hodgins, et al.. (2021). Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here. BMC Public Health. 21(1). 2084–2084. 24 indexed citations

Lamontagne, Erik, Mead Over, & John Stover. (2018). The economic returns of ending the AIDS epidemic as a public health threat. Health Policy. 123(1). 104–108. 17 indexed citations

Hauck, Katharina, Alec Morton, Kalipso Chalkidou, et al.. (2018). How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations. Social Science & Medicine. 220. 141–149. 29 indexed citations

Ghys, Peter D., Brian Williams, Mead Over, Timothy B. Hallett, & Peter Godfrey‐Faussett. (2018). Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS Medicine. 15(10). e1002678–e1002678. 48 indexed citations

Mikkelsen, Evelinn, Jan A. C. Hontelez, Maarten Jansen, et al.. (2017). Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints. PLoS Medicine. 14(2). e1002240–e1002240. 31 indexed citations

Fox, Matthew P., Owen J. McCarthy, & Mead Over. (2013). A Novel Approach to Accounting for Loss to Follow-Up when Estimating the Relationship between CD4 Count at ART Initiation and Mortality. PLoS ONE. 8(7). e69300–e69300. 5 indexed citations

Meyer‐Rath, Gesine & Mead Over. (2012). HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions. PLoS Medicine. 9(7). e1001247–e1001247. 50 indexed citations

Marseille, Elliot, Mark J Giganti, Albert Mwango, et al.. (2012). Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia. PLoS ONE. 7(12). e51993–e51993. 42 indexed citations

Over, Mead. (2010). Opportunities for Presidential Leadership on AIDS: From an “Emergency Plan” to a Sustainable Policy. Revue d économie du développement. Vol. 17(5). 71–105. 2 indexed citations

10.

Over, Mead. (2009). Échec de la prévention : le poids croissant des droits engendrés par l'aide américaine au financement du traitement mondial contre le VIH/SIDA et la voie à suivre. Revue d économie du développement. Vol. 17(1). 107–144. 3 indexed citations

11.

Over, Mead, Ana Revenga, Wiwat Peerapatanapokin, et al.. (2007). The economics of effective AIDS treatment in Thailand. AIDS. 21(Suppl 4). S105–S116. 34 indexed citations

12.

Marseille, Elliot, Lalit Dandona, Nell Marshall, et al.. (2007). HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Services Research. 7(1). 108–108. 65 indexed citations

13.

Laxminarayan, Ramanan, Mead Over, & David L. Smith. (2006). Will A Global Subsidy Of New Antimalarials Delay The Emergence Of Resistance And Save Lives?. Health Affairs. 25(2). 325–336. 38 indexed citations

14.

Over, Mead, Elliot Marseille, Julian Gold, et al.. (2006). Antiretroviral Therapy and HIV Prevention in India: Modeling Costs and Consequences of Policy Options. Sexually Transmitted Diseases. 33(Supplement). S145–S152. 31 indexed citations

15.

Dandona, Lalit, et al.. (2005). Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India. BMC Health Services Research. 5(1). 69–69. 24 indexed citations

16.

Over, Mead, Peter Heywood, Julian Gold, et al.. (2004). HIV/AIDS Treatment and Prevention in India : Modeling the Cost and Consequences. World Bank Publications. 2 indexed citations

17.

Over, Mead. (1999). Confronting AIDS: A Global Economic Perspective*. AIDS Patient Care and STDs. 13(4). 219–228. 2 indexed citations

18.

Ainsworth, Martha & Mead Over. (1998). AIDS and development: the role of government.. AIDS. 12. 4 indexed citations

19.

Over, Mead & Peter Piot. (1996). Human Immunodeficiency Virus Infection And Other Sexually Transmitted Diseases In Developing Countries: Public Health Importance And Priorities For Resource Allocation. The Journal of Infectious Diseases. 174(Supplement 2). S162–S175. 67 indexed citations

20.

Phillips, Michael, et al.. (1993). Adult health: a legitimate concern for developing countries.. American Journal of Public Health. 83(11). 1527–1530. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact